PD-L1+CD3+CD8+ % and PD-L1+CD20+ % were statistically higher in the NHL subjects than in the controls (median = 8.1 vs. 0.5 and 16 vs. 1, respectively; p < 0.001). This evidence concerns the gene CD8A and non-Hodgkin lymphoma.